Do Supplements Actually Work? An Honest Look at the $200 Billion Industry

What the science says, what the labels hide, and a framework for telling them apart.

Quick Summary

Do supplements work? The honest answer is: it depends on which supplement, for what condition, in which population, at what dose. Some have rigorous human evidence (creatine for muscle strength, omega-3 EPA/DHA for cardiovascular outcomes, vitamin D for documented deficiency, specific probiotic strains for specific conditions).^1,2,3 Others have promising but incomplete evidence (ashwagandha, berberine, magnesium for sleep). A meaningful share of the global $200 billion supplement industry is mostly marketing.⁴ The structural problem is the regulatory environment: under the 1994 Dietary Supplement Health and Education Act (DSHEA), manufacturers do not need to prove safety or efficacy before going to market, and the product count has grown from roughly 4,000 in 1994 to more than 80,000 today.⁴ Independent testing finds quality problems in roughly 30 percent of multivitamins evaluated; FDA warning data identifies hundreds of brands containing undeclared pharmaceuticals.^5,6 This article gives you a framework for telling the worthwhile supplements from the rest, and shows what reading a label and a Certificate of Analysis actually looks like.

Key Terms

DSHEA (Dietary Supplement Health and Education Act, 1994): The federal law defining how supplements are regulated in the United States. Manufacturers do not need to prove safety or efficacy before marketing.

Structure/function claim: A permitted supplement claim describing how an ingredient supports normal body function (for example, "supports healthy immune function"). Distinct from disease claims, which require FDA approval.

Strain specificity: The principle that a probiotic's effects are determined by the specific bacterial strain, not by the species name alone. Lactobacillus rhamnosus GG and Lactobacillus rhamnosus generic are not interchangeable.

Certificate of Analysis (COA): Batch-specific laboratory documentation confirming a production run meets identity, purity, potency, and contaminant standards.

Proprietary blend: A label practice that groups multiple ingredients under one total weight without disclosing individual amounts. Legal under DSHEA. Often used to obscure under-dosing.

The Industry's Structural Problem

Most articles about supplements start with whether a particular product works. That's the wrong starting point. The right starting point is the regulatory environment, because the regulatory environment is the reason the question is hard to answer in the first place.

In the United States, dietary supplements are governed by the 1994 Dietary Supplement Health and Education Act, usually shortened to DSHEA.⁴ Under DSHEA, the burden of proof is reversed compared to pharmaceuticals: manufacturers do not need to demonstrate safety or efficacy to the FDA before bringing a product to market. The FDA's enforcement is largely post-market, meaning the agency acts after problems are documented rather than before products are sold.

The result is visible in the numbers. The supplement product landscape grew from roughly 4,000 products at the time DSHEA passed to more than 80,000 products today.⁴ The global market is now estimated above $200 billion. That growth has happened without a corresponding pre-market evaluation infrastructure, which is part of why label accuracy and ingredient honesty are persistent issues across the category.

The industry is not unregulated. That framing is technically inaccurate and worth correcting. There are Good Manufacturing Practice (GMP) requirements under 21 CFR 111, the FTC enforces advertising standards, and the FDA pursues individual products it identifies as adulterated or misbranded. The accurate way to describe the situation is insufficient pre-market oversight, not absence of regulation.

That distinction matters because the structural problem is not that no one is watching. It is that the watching happens after the products are already on shelves.

A Tiered Way to Read the Evidence

The most useful way to evaluate any supplement is to ask three questions in order.

First: what condition or outcome are we talking about, and in what population? "Does this supplement work" is unanswerable as a general question. "Does this strain at this dose for this condition in adults of this age" is answerable.

Second: what is the strength of the evidence? A meta-analysis of multiple randomized controlled trials carries more weight than a single small study. A clinical guideline that includes the supplement carries more weight than mechanistic interest. Animal data and in vitro work are explanatory context, not clinical proof.

Third: how does the evidence translate to actual product choice? A supplement with strong evidence for a specific strain at a specific dose still requires you to find a product that contains that strain at that dose, in a form that survives manufacturing and storage. Evidence quality and product quality are independent variables. You need both.

The tiered framework that follows applies these three questions to specific supplement categories. Tier 1 supplements have strong, well-replicated human evidence for specific outcomes. Tier 2 supplements have promising evidence with meaningful gaps. Tier 3 supplements are mostly marketing.

Tier 1: Supplements With Strong Human Evidence

A short list of supplements where the human evidence is strong enough to take seriously, with the caveats that always apply.

Creatine is one of the best-studied ergogenic supplements in the field. Meta-analyses of randomized controlled trials consistently show significant improvements in muscle strength in both trained and untrained populations.¹ Creatine does not replace training. It improves training outcomes and is increasingly studied for non-athletic contexts including cognitive support and sarcopenia prevention in older adults.

Omega-3 EPA/DHA is the supplement category with the strongest cardiovascular evidence base. A meta-analysis of 38 randomized controlled trials including more than 149,000 participants found that omega-3 supplementation is associated with reduced cardiovascular mortality, with EPA-only formulations showing greater effect than combined EPA+DHA.² A dose-response relationship is present; the highest-effect trials used substantial daily doses (4 grams per day in REDUCE-IT) that may not match typical over-the-counter dosing.

Vitamin D is the deficiency-correction story. Supplementation reliably raises serum vitamin D in deficient individuals and is associated with reduced all-cause mortality in good- and fair-quality randomized trials.³ The clinical guidelines do not generally recommend routine supplementation in non-deficient adults; the strong evidence is for correcting documented deficiency, not for population-wide use.

Specific probiotic strains, for specific conditions, in specific populations. Lactobacillus rhamnosus GG (LGG) has demonstrated efficacy for prevention of antibiotic-associated diarrhea in children, with a meta-analysis relative risk of approximately 0.44.⁷ This finding does not extend to adults, to other strains of L. rhamnosus, or to other digestive conditions without independent evidence. The strain specificity is the point, and is covered in detail later.

Magnesium is widely under-consumed in the US population (roughly 45 to 50 percent of adults fall short of the recommended daily intake). It plays a role in more than 300 enzymatic reactions and is associated with sleep quality improvements in trials, particularly in those with low baseline magnesium status.⁸

The shared pattern across Tier 1 is specificity. Each of these supplements has evidence for a defined outcome, in a defined population, at a defined dose. None of them is a general "wellness" recommendation.

Tier 2: Promising but Incomplete

Tier 2 is where most consumer confusion happens. The supplements are not snake oil. The evidence is not yet strong enough to recommend them the way Tier 1 supplements can be recommended.

Ashwagandha has been studied for stress and anxiety in multiple small to mid-size randomized controlled trials. A 2023 meta-analysis of 22 RCTs (1,391 adults) found significant reductions in validated stress, anxiety, and depression scales, with a dose-response signal at 500 to 600 mg per day.⁹ The caveats matter. The studies are predominantly conducted in Indian adult populations, durations are short (6 to 12 weeks), and ashwagandha is not included in clinical anxiety guidelines. It should not be presented as a substitute for evidence-based pharmacological or psychological treatment of anxiety disorders.

Berberine is the supplement most often described as a "natural Ozempic" in popular content. The evidence is more measured. Multiple meta-analyses and an umbrella review have found berberine associated with reductions in fasting blood glucose, HbA1c, triglycerides, and LDL cholesterol in adults with metabolic dysfunction or type 2 diabetes.¹⁰ Most trials are small, conducted in China, and not compared head-to-head with standard pharmacological treatments. Berberine also interacts with antidiabetic medications, which means it is not a casual addition to a regimen that includes prescribed diabetes management.

Lion's mane is the cleanest example of a supplement where mechanistic interest has run ahead of human evidence. Animal and in vitro data on NGF and BDNF pathways are intriguing. Human clinical evidence is limited and inconsistent: one small unreplicated RCT in mild cognitive impairment showed benefit, while a 4-week trial in college-age adults found no significant cognitive effects.¹¹ The Alzheimer's Drug Discovery Foundation's evidence summary is appropriately cautious. Current human evidence does not support recommending lion's mane for cognitive enhancement in healthy adults.

Magnesium for sleep and anxiety, specifically. While Tier 1 covers magnesium broadly, the sleep and anxiety claims sit in Tier 2. Some randomized trials report improvements in sleep quality measures, with effects most consistent in individuals with low baseline magnesium status.¹² Evidence is heterogeneous, effect sizes are modest, and different formulations (citrate, glycinate, oxide) likely have different absorption profiles.

The pattern in Tier 2 is that the science is interesting and the marketing is ahead of it. These supplements may genuinely help some people. They are not yet at the level of evidence that supports general recommendation.

Tier 3: Mostly Marketing

Some supplement categories live almost entirely on marketing rather than evidence.

Weight-loss supplements and fat burners lead the list. The FDA has issued hundreds of public notifications about contaminated weight-loss products. The FTC has been explicit: any promise of substantial, sustained weight loss from a supplement without dietary and lifestyle changes is, in their words, simply untrue.¹³ Some ingredients (caffeine, for instance) have minor thermogenic effects. None produce clinically meaningful fat loss without changes elsewhere in the picture.

"Detox" products are the second category that disappears under examination. No regulatory body or scientific organization recognizes "detox" as a meaningful physiological category. The liver, kidneys, gut, and lymphatic system perform endogenous detoxification continuously, without supplemental assistance. "Detox" is a category of marketing claims, not a category of physiological need.

Vague "immune boosters" are the third. "Immunity" as a marketing category is essentially open. Individual ingredients (vitamin C, zinc, elderberry) have limited and often context-specific evidence. None of them supports the broad framing of "boost your immune system" that defines this category.

These three categories share an unpleasant feature: they are the same categories where pharmaceutical adulteration is most concentrated. A 2018 JAMA Network Open analysis of FDA warning data identified 776 supplement brands containing undeclared pharmaceutical ingredients between 2007 and 2016, with weight-loss, sexual enhancement, and muscle-building products responsible for the majority of cases.⁶ A CDC/FDA surveillance study estimated approximately 23,000 emergency department visits annually attributable to dietary supplements, with weight-loss and energy products responsible for a disproportionate share among adults aged 5 to 34.¹⁴

Independent testing tells a parallel story. ConsumerLab's 2023 multivitamin review found that nearly 30 percent of products tested failed quality review, including products with as little as 14 percent of stated vitamin D and gummies with nearly double their claimed folic acid.⁵ Quality problems are not exotic. They are a baseline feature of the category.

The Probiotic Problem (Why Strain Matters More Than CFU)

The probiotic category deserves its own section because it is uniquely confusing for consumers, and because most of the confusion is solvable with one piece of education.

The official definition of a probiotic is "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host." The phrase that gets ignored in most product marketing is "specific microorganisms" and "adequate amounts." Probiotic effects are simultaneously strain-specific, disease-specific, dose-specific, and population-specific. A Lactobacillus rhamnosus GG study showing reduced antibiotic-associated diarrhea in children does not translate to Lactobacillus rhamnosus generic, to other species in the Lactobacillus genus, or to adults with a different condition.⁷

This is the heart of the CFU myth. CFU (colony forming units) measures how many live bacteria are in a dose. More is not always better. The right strain at an appropriate dose for the right condition is the determinant of effect. Adding more CFUs of the wrong strain does not produce additive benefit.

A second piece of education that helps: probiotic blends that list neither specific strains nor individual CFU counts cannot be evaluated. If a label reads "8 billion CFU per dose, multi-strain blend including Lactobacillus, Bifidobacterium, and others," there is no way to know which specific strains are in it, at what doses, in what proportions. That is by design under proprietary blend labeling, which is legal under DSHEA and routinely used to obscure under-dosing of clinically validated strains in favor of larger amounts of cheaper, less-studied ones.

A third piece, less commonly discussed: delivery format matters. Probiotic viability is reduced by gastric acid exposure. Delayed-release capsule formulations show significantly higher proportions of viable bacteria reaching the small and large intestine than standard capsules. A high-CFU product in a poor delivery format can deliver fewer viable bacteria to the intended site than a moderate-CFU product in a well-designed format.

The practical implication for consumers is that "is this a good probiotic" is not a meaningful question. The meaningful questions are: which specific strains does it contain (named at the strain level), at what dose per strain, in what delivery format, and is there evidence for those strains at those doses for the condition you care about.

"Natural" Does Not Mean "Safe"

One more myth worth retiring. The framing that "natural" supplements are inherently safe is contradicted by clinical toxicology and by regulatory history.

Kava, used as a traditional ceremonial drink in the South Pacific, has been linked to more than 100 documented cases of liver-related injury including hepatitis, cirrhosis, and liver failure requiring transplantation. Multiple countries (Germany, Switzerland, France, Canada, the United Kingdom) have banned or restricted it.¹⁵

Aristolochic acid, found in some traditional Chinese herbal preparations, causes progressive renal fibrosis (aristolochic acid nephropathy) and urothelial cancers. It has been banned in multiple jurisdictions.¹⁵

Ephedra, used in weight-loss and energy products, was associated with hepatotoxicity, neurotoxicity, cardiac events, and stroke. The FDA banned it as a supplement ingredient in 2004.¹⁵

These three ingredients are all botanical in origin. The framing of "natural" as a safety signal does not survive contact with the underlying clinical record. None of this argues against herbs in general. It argues for evaluating individual ingredients on their actual safety and efficacy data, not on whether they originated in a plant.

How to Read a Supplement Label

Before you buy any supplement, four questions are worth asking. These work for any category, not just probiotics.

1. What is in it, by ingredient and by dose? A trustworthy label lists each active ingredient with its dose. Proprietary blends that group multiple ingredients under a single total weight do not allow this evaluation. A label that hides individual doses in a blend should be treated as failing this question.

2. Is there third-party testing or certification? USP Verified, NSF Certified, and ConsumerLab Approved are the three major independent certification programs. They verify that the product contains what the label says, free of specified contaminants, at appropriate dissolution. They do not certify that the product works. Both pieces matter. Quality testing without efficacy evidence is necessary but not sufficient.

3. Is there a Certificate of Analysis (COA) available? A COA is a batch-specific document confirming that a production run met identity, purity, potency, and contaminant standards under FDA cGMP regulations (21 CFR 111). Trustworthy manufacturers make COAs available on request. Ask for one. If a manufacturer cannot or will not provide a COA for the specific batch you have, that is a meaningful signal.

4. For probiotics specifically: are strains named at the strain level, with individual CFU counts per strain at end of shelf life (not at manufacture)? Strain-level naming (genus + species + strain designation, like Lactobacillus rhamnosus GG or Lactobacillus acidophilus LA-5) is the standard. CFU at end of shelf life accounts for natural die-off during storage; CFU at manufacture is a marketing-favorable number that does not reflect what you will actually consume.

These four questions filter out a meaningful share of the supplement market. Many products will fail one or more of them. That is information.

The Worked Example: Applying the Framework

Here is the framework applied to a real product. WonderBiotics Probiotics for Gut Health meets the criteria: every strain is named at the strain level with its individual CFU dose at end of shelf life, the formulation avoids proprietary blends, the products are manufactured under cGMP standards with documented batch-level Certificates of Analysis available on request, and the underlying strains are selected for documented evidence in their respective use cases. Consumers can demand the same level of transparency from any supplement they consider buying.

The same questions, applied to a different product, would produce a different verdict. That is the framework working as intended. Apply it to any product, and it will help you evaluate that product on its actual merits.

Practical Takeaways

A short list of the most useful actions, in priority order.

• Decide what outcome you actually care about. "Better gut health" is too general. "Reduce constipation when traveling" is specific. Specific questions can be answered. General ones cannot.
• Check the evidence tier. Is your target outcome supported by Tier 1 evidence (creatine for strength, omega-3 for cardiovascular, vitamin D for documented deficiency, specific strains for specific conditions), Tier 2 (ashwagandha, berberine, magnesium with population caveats), or Tier 3 (mostly marketing)? The tier should shape both your expectations and your willingness to spend.
• Read the label. Individual ingredient doses, no proprietary blends. For probiotics, strain-level naming and CFU per strain at end of shelf life.
• Check for third-party testing. USP, NSF, or ConsumerLab. Confirms quality, not efficacy.
• Ask for a Certificate of Analysis. Trustworthy manufacturers provide them on request. Refusal or inability to provide one is meaningful.
• Be skeptical of weight-loss, sexual enhancement, and muscle-building products. These are the categories with the most documented adulteration and quality risk.
• Treat "natural" as a marketing word, not a safety claim. Kava, aristolochic acid, and ephedra are reminders that botanical origin does not guarantee safe use.
• Talk to a clinician if you are managing a clinical condition or taking medications. Berberine and antidiabetic medications, ashwagandha and thyroid medication, and several other supplement-drug interactions are real and consequential.

The Bigger Picture

The supplement industry's structural problem is not that the science is missing. It is that the regulatory environment makes it hard for consumers to find the science when it does exist. Some supplements have rigorous human evidence for specific outcomes in specific populations. Others have promising signals that are not yet at recommendation strength. Many are mostly marketing wrapped around minimal substance.

What you are left with is a framework, not a verdict. The tier framework, the four label questions, the strain-specificity rule for probiotics, the COA standard, the "natural is not the same as safe" reminder. These are tools that work on any supplement you encounter, including the ones not yet invented at the time this is being written. The point is to put you in a position to read the evidence yourself, ask better questions of any product you consider, and recognize when an industry has set up the answers to be conveniently confusing. The industry can stay structurally noisy. You do not have to.

Related Reading

• For a closer look at probiotics specifically, including how to evaluate strain claims, read What Are Probiotics? Benefits, Risks, and How to Choose the Right Supplement.
• For a step-by-step on the label questions covered in the framework, see How to Read a Probiotic Label.
• For a deeper read on evidence-based supplement evaluation, try Clean Nutraceuticals: An Evidence-Based Guide.
• If the Tier 2 berberine section piqued interest, here's the full picture: What Is Berberine? And Why Is Everyone Talking About It.
• For more on the Tier 1 creatine evidence, especially for women, read Creatine Gummies for Women: What You Need to Know.

References

1. Liu P, et al. Effects of creatine supplementation on muscle strength gains: A systematic review and meta-analysis of randomized controlled trials. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12665265/
2. Bhatt DL, et al. Meta-analysis of 38 RCTs: omega-3 fatty acids and cardiovascular outcomes. eClinicalMedicine / Brigham and Women's Hospital. 2021. https://www.sciencedaily.com/releases/2021/07/210708083854.htm
3. Pittas A, et al. Vitamin D supplementation and its impact on mortality and cardiovascular outcomes. PMC. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10146299/
4. FDA. Information for Consumers on Using Dietary Supplements. FDA.gov. https://www.fda.gov/food/dietary-supplements/information-consumers-using-dietary-supplements
5. ConsumerLab.com. Nearly 30% of Multivitamins Fail ConsumerLab Tests. 2023. https://www.consumerlab.com/news/best-and-worst-multivitamins/05-25-2023/
6. Tucker J, Fischer T, et al. Unapproved Pharmaceutical Ingredients in Dietary Supplements Associated With US FDA Warnings. JAMA Network Open. 2018. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2706496
7. Szajewska H, et al. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: Systematic Review and Meta-Analysis. Frontiers in Medicine / PMC. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC5949321/
8. Rawji V, et al. Examining the Effects of Supplemental Magnesium on Self-Reported Anxiety and Sleep Quality. PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11136869/
9. NIH Office of Dietary Supplements. Ashwagandha: Is It Helpful for Stress, Anxiety, or Sleep? Health Professional Factsheet. https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/
10. Papalimneou A, et al. The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Markers: An Umbrella Review of Meta-Analyses. Clinical Therapeutics. 2023. https://www.sciencedirect.com/science/article/abs/pii/S0149291823004290
11. Alzheimer's Drug Discovery Foundation. Lion's Mane Mushroom: Cognitive Vitality Evidence Summary for Researchers. ADDF Cognitive Vitality. 2022. https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Lions-Mane-Cognitive-Vitality-For-Researchers.pdf
12. Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress: A Systematic Review. Nutrients. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5452159/
13. FTC. Health Products Compliance Guidance. Federal Trade Commission. 2022. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
14. Geller AI, et al. Emergency Department Visits for Adverse Events Related to Dietary Supplements. New England Journal of Medicine / CDC and FDA collaborative study. 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC6196363/
15. Izzo AA, et al. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology / PMC. 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC3887317/